NCT05091723
- Conditions
- Acute Lung Injury, Acute Lung Injury (ALI) Due to Coronavirus Disease-2019 (COVID-19), COVID-19, +12 more
- Locations
-
- Theravance Biopharma Investigational Site Cypress, California, United States
Clinical trial condition
Acute Lung Injury (ALI) Due to Coronavirus Disease-2019 (COVID-19)
Explore clinical trials studying Acute Lung Injury (ALI) Due to Coronavirus Disease-2019 (COVID-19). Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies